Tanaka, A., Nishikawa, H., Noguchi, S., Sugiyama, D., Morikawa, H., Takeuchi, Y., . . . Sakaguchi, S. (2019). Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells. J Exp Med.
Styl cytowania ChicagoTanaka, Atsushi, et al. "Tyrosine Kinase Inhibitor Imatinib Augments Tumor Immunity By Depleting Effector Regulatory T Cells." J Exp Med 2019.
Styl cytowania MLATanaka, Atsushi, et al. "Tyrosine Kinase Inhibitor Imatinib Augments Tumor Immunity By Depleting Effector Regulatory T Cells." J Exp Med 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..